513 related articles for article (PubMed ID: 21775467)
1. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.
Jaume M; Yip MS; Cheung CY; Leung HL; Li PH; Kien F; Dutry I; Callendret B; Escriou N; Altmeyer R; Nal B; Daëron M; Bruzzone R; Peiris JS
J Virol; 2011 Oct; 85(20):10582-97. PubMed ID: 21775467
[TBL] [Abstract][Full Text] [Related]
2. SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.
Jaume M; Yip MS; Kam YW; Cheung CY; Kien F; Roberts A; Li PH; Dutry I; Escriou N; Daeron M; Bruzzone R; Subbarao K; Peiris JS; Nal B; Altmeyer R
Hong Kong Med J; 2012 Feb; 18 Suppl 2():31-6. PubMed ID: 22311359
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.
Kam YW; Kien F; Roberts A; Cheung YC; Lamirande EW; Vogel L; Chu SL; Tse J; Guarner J; Zaki SR; Subbarao K; Peiris M; Nal B; Altmeyer R
Vaccine; 2007 Jan; 25(4):729-40. PubMed ID: 17049691
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.
Yip MS; Leung NH; Cheung CY; Li PH; Lee HH; Daëron M; Peiris JS; Bruzzone R; Jaume M
Virol J; 2014 May; 11():82. PubMed ID: 24885320
[TBL] [Abstract][Full Text] [Related]
6. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
Hofmann H; Hattermann K; Marzi A; Gramberg T; Geier M; Krumbiegel M; Kuate S; Uberla K; Niedrig M; Pöhlmann S
J Virol; 2004 Jun; 78(12):6134-42. PubMed ID: 15163706
[TBL] [Abstract][Full Text] [Related]
7. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
8. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.
Wang H; Yang P; Liu K; Guo F; Zhang Y; Zhang G; Jiang C
Cell Res; 2008 Feb; 18(2):290-301. PubMed ID: 18227861
[TBL] [Abstract][Full Text] [Related]
9. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y; Shang J; Sun S; Tai W; Chen J; Geng Q; He L; Chen Y; Wu J; Shi Z; Zhou Y; Du L; Li F
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826992
[TBL] [Abstract][Full Text] [Related]
11. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
[TBL] [Abstract][Full Text] [Related]
12. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
13. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
Glowacka I; Bertram S; Müller MA; Allen P; Soilleux E; Pfefferle S; Steffen I; Tsegaye TS; He Y; Gnirss K; Niemeyer D; Schneider H; Drosten C; Pöhlmann S
J Virol; 2011 May; 85(9):4122-34. PubMed ID: 21325420
[TBL] [Abstract][Full Text] [Related]
14. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
15. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
[TBL] [Abstract][Full Text] [Related]
16. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
Kam YW; Okumura Y; Kido H; Ng LF; Bruzzone R; Altmeyer R
PLoS One; 2009 Nov; 4(11):e7870. PubMed ID: 19924243
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
Fukushi S; Watanabe R; Taguchi F
Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
[TBL] [Abstract][Full Text] [Related]
19. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
[TBL] [Abstract][Full Text] [Related]
20. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
Yi CE; Ba L; Zhang L; Ho DD; Chen Z
J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
